UCLA Gets $11.6M in NCI Funding for Prostate Cancer Program | GenomeWeb

NEW YORK (GenomeWeb News) – The University of California Los Angeles said today that its Jonsson Comprehensive Cancer Center (JCCC) and David Geffen School of Medicine have received $11.6 million from the National Cancer Institute to fuel a range of molecular research projects focused on prostate cancer.

The award continues providing funding for the center and the medical school to serve as a Specialized Program of Research Excellence (SPORE) for five years. It is the third grant they have received to fund this SPORE.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Sponsored by
Agilent Technologies

This webinar will provide specific use cases from a molecular pathology lab demonstrating how an automated bioinformatics pipeline can improve somatic variant assessment and reporting.